H. Weedon-Fekjaer

Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling

S. Plevritis, D. Miglioretti, A. Trentham-Dietz, 2018, Medical decision making : an international journal of the Society for Medical Decision Making.

“Natural course” of disease in patients with metastatic castrate-resistant prostate cancer: Survival and prognostic factors without life-prolonging treatment

S. Fosså, S. Löffeler, E. Haug, 2015, Scandinavian journal of urology.

Statistical advising: Professional development opportunities for the biostatistician

Eric A. Vance, Morten Wang Fagerland, M. Posch, 2022, Statistics in medicine.

Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010).

S. Fosså, C. Tropé, H. Weedon-Fekjær, 2014, European journal of cancer.

Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results

Odd O Aalen, Harald Weedon-Fekjaer, Bo Lindqvist, 2005, Journal of medical screening.

Plasma concentration of atorvastatin metabolites correlates with low‐density lipoprotein cholesterol reduction in patients with coronary heart disease

J. Munkhaugen, E. Sverre, S. Bergan, 2023, Pharmacology research & perspectives.

Preventable clinical and psychosocial factors predicted two out of three recurrent cardiovascular events in a coronary population

T. Dammen, J. Munkhaugen, H. Weedon-Fekjær, 2020, BMC Cardiovascular Disorders.

Hormone therapy use may explain recent results regarding tumor regression.

R. Sørum, H. Weedon-Fekjaer, Marianne Kolstad Brenn, 2009, Archives of internal medicine.